Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Axogen (AXGN) Revenue (2016 - 2025)

Historic Revenue for Axogen (AXGN) over the last 16 years, with Q3 2025 value amounting to $60.1 million.

  • Axogen's Revenue rose 2351.37% to $60.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $214.7 million, marking a year-over-year increase of 1871.82%. This contributed to the annual value of $187.3 million for FY2024, which is 1781.37% up from last year.
  • Per Axogen's latest filing, its Revenue stood at $60.1 million for Q3 2025, which was up 2351.37% from $56.7 million recorded in Q2 2025.
  • Axogen's 5-year Revenue high stood at $60.1 million for Q3 2025, and its period low was $31.0 million during Q1 2022.
  • Moreover, its 5-year median value for Revenue was $38.2 million (2023), whereas its average is $40.9 million.
  • Within the past 5 years, the most significant YoY rise in Axogen's Revenue was 5183.58% (2021), while the steepest drop was 665.31% (2021).
  • Axogen's Revenue (Quarter) stood at $31.5 million in 2021, then grew by 14.67% to $36.2 million in 2022, then grew by 18.69% to $42.9 million in 2023, then rose by 15.1% to $49.4 million in 2024, then grew by 21.61% to $60.1 million in 2025.
  • Its Revenue stands at $60.1 million for Q3 2025, versus $56.7 million for Q2 2025 and $48.6 million for Q1 2025.